Program at a Glance
Home > Program > Program at a Glance
  • - Session times are Korea Standard Time (UTC/GMT+9). Please click the Time Zone Converter button and check your local time.
  • - The program is subject to change.
  • - If you click the session code, it will lead you to details of the scientific programs.
  • - We will notify you later about the details of the poster/oral presentation.
  • Program at a Glance
  • September 7 (THU)
  • September 8 (FRI)

SESSION CODE:
[PL] Plenary Lecture, [SS] Scientific Symposium, [JS] Joint Symposium, [ES] Education Session,
[MDCD] Multi-Disciplinary Case Discussion, [OP] Oral Presentation, [LS] Luncheon Symposium, [SL] Satellite Symposium

Date September 7 (THU)
Time Room A Room B Room C Room D Room E
08:00-08:40          
08:40-10:10 JS 1 (90')
ASCO/KSMO
Joint Symposium 1
SL 1 (40')

SS 1 (90')
IO
SS 2 (90')
GU
 
Break (10')
SL 2 (40')

10:10-10:30 Opening Ceremony (20')    
10:30-10:40 Break (10')
10:40-11:20 PL 1 (40')    
11:20-11:30 Break (10')
11:30-12:10 LS 1 (40')

  LS 2 (40')

  LS 3 (40')

12:10-12:30 Break (20')
12:30-14:00 SS 3 (90')
Lung
SL 3 (40')

JS 2 (90')
KSP/KSMO
Joint Symposium
JS 3 (90')
KCSG/KSMO
Joint Symposium
 
Break (10')
SL 4 (40')

14:00-14:10 Break (10')
14:10-15:40 SS 4 (90')
GI 1
Collaborative
Symposium (40’)
(14:10-14:50 )

JS 4 (90')
KOSRO/KSMO
Joint Symposium
SS 5 (90')
Genomics
 
OP 1 (60')
(14:40-15:40)
 
15:40-15:50 Break (10')
15:50-16:30 PL 2 (40')        
16:30-18:00 JS 5 (90')
ESMO/KSMO
Joint Symposium 1
SL 5 (40')

SS 6 (90')
Big Data/AI
SS 7 (90')
Novel
 
Break (10')
SL 6 (40')

Date September 8 (FRI)
Time Room A Room B Room C Room D Room E
08:00-08:40 SL 7 (40')

  SL 8 (40')

SL 9 (40')

SL 10 (40')

08:40-09:00 Break (20') Break (20')
09:00-09:40 PL 3 (40')        
09:40-10:00 Break (20')  
10:00-11:30 JS 6 (90')
ASCO/KSMO
Joint Symposium 2
SL 11 (40')

SS 8 (90')
GI 2
  ES 1 (80')
(10:00-11:20)

 
Break (10')  
SL 12 (40')

 
   
11:30-11:40 Break (10')
11:40-12:20 LS 4 (40')

  LS 5 (40')

LS 6 (40')

 
12:20-12:40 Break (20')
12:40-14:10 SS 9 (90')
Breast
SL 13 (40')

JS 7 (90')
JSMO/KSMO
Joint Symposium
Master Class (100')
(12:40-14:20)



ES 2 (90')

 
 
14:10-14:20 Break (10') Break (10')
14:20-15:00 PL 4 (40')        
15:00-16:00 JS 8 (60')
KSR/KSMO
Joint Symposium
OP 2 (60') MDCD (60')

ES 3 (90')
(15:00-16:30)

FACO 1 (60')
16:00-16:10 Break (10') Break (10')
16:10-17:40 JS 9 (90')
ESMO/KSMO
Joint Symposium 2
SL 14 (40')

JS 10 (90')
KSSO/KSMO
Joint Symposium
FACO 2 (90')
Break (10')  
SL 15 (40')

 
17:40-18:00 Closing & Awards Ceremony (20')        
Date September 7 (THU)
Time Room A Room B Room C Room D Room E
08:00-08:40          
08:40-10:10 JS 1 (90')
ASCO/KSMO Joint Symposium 1

Targeting rare genomic aberrations in precision oncology
SL 1 (40')

SS 1 (90')
IO

T cells need our help to fight cancer, beyond PD-1/PD-L1 inhibitors
SS 2 (90')
GU

The next step in the treatment of GU cancers
 
Break (10')
SL 2 (40')

10:10-10:30 Opening Ceremony (20')  
10:30-10:40 Break (10')
10:40-11:20 PL 1 (40')
Mechanisms of resistance to endocrine therapy in ER+ breast cancer
 
11:20-11:30 Break (10')
11:30-12:10 LS 1 (40')

  LS 2 (40')

  LS 3 (40')

12:10-12:30 Break (20')
12:30-14:00 SS 3 (90')
Lung

Treatment for NSCLC: The earlier, the better?
SL 3 (40')

JS 2 (90')
KSP/KSMO Joint Symposium

Location matters: How spatial data is driving precision medicine
JS 3 (90')
KCSG/KSMO Joint Symposium

The near future of precision medicine - One more step
 
Break (10')
SL 4 (40')

14:00-14:10 Break (10')
14:10-15:40 SS 4 (90')
GI 1

Advance of perioperative chemotherapy in resectable or potentially resectable GI cancer
Collaborative Symposium
(40’) (14:10-14:50 )

Antibody-Drug Conjugates: Rise of new therapeutic strategies

JS 4 (90')
KOSRO/KSMO Joint Symposium

Advances in non-operative,
organ-preserving strategy
SS 5 (90')
Genomics

Advances in genomics technology and its clinical adaptation
 
OP 1 (60')
(14:40-15:40)
 
15:40-15:50 Break (10')
15:50-16:30 PL 2 (40')
Mechanism of Action and Inflammatory Axis for Air Pollution Induced Non-Small Cell Lung Cancer
       
16:30-18:00 JS 5 (90')
ESMO/KSMO Joint Symposium 1

Multiomics approach for
precision medicine
SL 5 (40')

SS 6 (90')
Big Data/AI

Artificial intelligence-empowered precision medicine in oncology: Cancer diagnosis, biomarker development, and drug discovery
SS 7 (90')
Novel

The blueprint for next-generation therapeutics
 
Break (10')
SL 6 (40')

Date September 8 (FRI)
Time Room A Room B Room C Room D Room E
08:00-08:40 SL 7 (40')

  SL 8 (40')

SL 9 (40')

SL 10 (40')

08:40-09:00 Break (20') Break (20')
09:00-09:40 PL 3 (40')
SCRUM-MONSTAR & CIRCULATE
- Japan platform to accelerate precision oncology innovations; achievement and perspective
       
09:40-10:00 Break (20')  
10:00-11:30 JS 6 (90')
ASCO/KSMO Joint Symposium 2

Recent updates in multimodality cancer treatment
SL 11 (40')

SS 8 (90')
GI 2

Recent strategies in treatment advances for metastatic GI cancers
  ES 1 (80')
(10:00-11:20)

Basics of precision medicine for medical oncologists: What else should we know beyond NGS?

 
Break (10')
SL 12 (40')

 
   
11:30-11:40 Break (10')
11:40-12:20 LS 4 (40')

  LS 5 (40')

LS 6 (40')

 
12:20-12:40 Break (20')
12:40-14:10 SS 9 (90')
Breast

Recent advances in
breast cancer treatment
SL 13 (40')

JS 7 (90')
JSMO/KSMO Joint Symposium

Emerging immuno-oncology strategy in solid tumors
Master Class (100')
(12:40-14:20)



ES 2 (90')

Practical points in conducting clinical trials

 
 
14:10-14:20 Break (10') Break (10')
14:20-15:00 PL 4 (40')
The past & future journey of cancer immunotherapy
       
15:00-16:00 JS 8 (60')
KSR/KSMO Joint Symposium

Integrating interventional techniques in the immunotherapy landscape: Novel insights from radiology and oncology
OP 2 (60') MDCD (60')

Multidisciplinary approach for patients with oligo-metastasis in the era of precision medicine

ES 3 (90')
(15:00-16:30)

ABCs of novel therapeutics for solid cancers: What should we know?

FACO 1 (60')

Recent updates in colorectal cancer treatment
16:00-16:10 Break (10')  
16:10-17:40 JS 9 (90')
ESMO/KSMO Joint Symposium 2

Immunooncology: Holistic perspectives for oncologists
SL 14 (40')

JS 10 (90')
KSSO/KSMO Joint Symposium

Hereditary cancer - Diagnosis & proper management
FACO 2 (90')

Proposals for new FACO clinical trials
Break (10')  
SL 15 (40')

 
17:40-18:00 Closing & Awards Ceremony (20')